Izotropic Corporation

Commercializing a Dedicated Breast CT Platform for the Earlier Detection, Diagnosis and Treatment of Breast Cancers

Recent News

  • Izotropic Corporation Announces Closing of Second Tranche of Non-Brokered Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - October 30, 2020) -  Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") - Further to the Company's News Release of October 20, 2020, the Company is pleased to announce that it has completed the second and final tranche of its non-brokered private placement financing (the "Offering"), whereby the Company issued 2,866,334 units (each, a "Unit") at a price of $0.55 per Unit for gross proceeds of $1,576,483.70. The Company received...

    2020-10-30 7:00 AM ET
  • Izotropic Corporation Announces Non-Brokered Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - October 20, 2020) -  Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company")  is pleased to announce a non-brokered private placement financing (the "Offering") of up to 6,000,000 units of the Company (each, a "Unit") at a price of $0.55 per Unit for gross proceeds of up to $3,300,000. Each Unit will consist of one common share and one transferable warrant (each, a "Warrant"), and each Warrant will entitle the...

    2020-10-20 7:00 AM ET
  • Izotropic Announces Meeting Date with FDA

    Vancouver, British Columbia--(Newsfile Corp. - September 28, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce that the Company's Executive and Scientific Advisory Teams will meet with the U.S. Food and Drug Administration (FDA) on October 20, 2020. Further to the news release issued August 18, 2020, the Company filed a Pre-Submission Application with the FDA which began the market approval process for the Company's commercial Breast CT...

    2020-09-28 7:00 AM ET
  • Mr. Alexander Tokman Joins Izotropic as Strategic Advisor

    Vancouver, British Columbia--(Newsfile Corp. - September 15, 2020) -  Izotropic Corporation ("Izotropic" or the "Company") (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) is pleased to announce the addition of Mr. Alexander Tokman as Strategic Advisor to the Company's growing advisory board. Mr. Tokman is a growth-driven executive leader with over 22 years of global, cross-functional profit and loss leadership, specializing in creating and commercializing new technology businesses in the Healthcare, Consumer Electronics and Semiconductor sectors for Fortune 100, technology Micro-Cap...

    2020-09-15 7:00 AM ET
  • Izotropic Engages MarketSmart Communications

    Vancouver, British Columbia--(Newsfile Corp. - August 31, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce it has entered into a consulting agreement with MarketSmart Communications Inc. (MarketSmart) to help build awareness of the company's corporate profile within the investment community.Established in 2002, MarketSmart has represented numerous successful public companies including SONA Nanotech Inc. (Symbol SONA), which has been an active client since February of this year. MarketSmart has...

    2020-08-31 7:00 AM ET
  • Izotropic Files Pre-Submission Application with U.S. FDA

    Vancouver, British Columbia--(Newsfile Corp. - August 18, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce that it has filed a Pre-Submission Application with the U.S. Food and Drug Administration (FDA) marking the beginning of the market approval process for the Company's commercial Breast CT Imaging System. The Pre-Submission Application filing has been a highly anticipated event for the Company and is a major milestone for the inventors, stakeholders...

    2020-08-18 7:00 AM ET
  • Izotropic Engages Dr. Craig Abbey for Breast CT Reader Study Design

    Vancouver, British Columbia--(Newsfile Corp. - July 8, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce that it has engaged Dr. Craig Abbey, Ph.D., to develop and present proposed reader study designs to the FDA during the Company's pre-submission meeting for approval of its Breast CT Imaging System. Dr. Abbey has a Ph.D. in Applied Mathematics and currently holds a professional Researcher position at the University of California,...

    2020-07-08 2:01 AM ET
  • Izotropic Corporation Appoints Executive Vice President of Commercial Operations

    Vancouver, British Columbia--(Newsfile Corp. - July 6, 2020) -  Izotropic Corporation (CSE: IZO) (OTC PINK: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce the appointment of John McGraw, Ph.D., as Executive Vice President of Commercial Operations.Dr. McGraw brings over 20 years of technology and business development experience spanning several medical device and healthcare-related market segments and has created and implemented successful strategies for the commercialization of new technologies in medical devices, imaging and laboratory diagnostics and therapeutics. He...

    2020-07-06 2:01 AM ET